You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Get the latest updates or take a self-assessment.

Published Research

Our researchers have published a large body of high-quality research on cancer and chronic kidney disease, as well as other health topics such as screening, survivorship, palliative care, sustainability, equity and health services.

For a list of our journal articles, visit PubMed.

Featured CCO Research Articles

Albaba H, Barnes TA, Veitch Z, Brown MC, Shakik S, Su S, Naik H, Wang T, Liang M, Perez-Cosio A, Eng L, Mittmann N, Xu W, Howell D, Liu G. Acceptability of Routine Evaluations Using Patient-Reported Outcomes of Common Terminology Criteria for Adverse Events and Other Patient-Reported Symptom Outcome Tools in Cancer Outpatients: Princess Margaret Cancer Centre Experience. Oncologist. 2019 Aug 13. pii: theoncologist.2018-0830. doi: 10.1634/theoncologist.2018-0830. [Epub ahead of print] PubMed PMID: 31409744. [Uses CCO data].


Alibhai SMH, Santa Mina D, Ritvo P, Tomlinson G, Sabiston C, Krahn M, Durbano S, Matthew A, Warde P, O'Neill M, Timilshina N, Segal R, Culos-Reed N. A phase II randomized controlled trial of three exercise delivery methods in men with prostate cancer on androgen deprivation therapy. BMC Cancer. 2019 Jan 3;19(1):2. doi: 10.1186/s12885-018-5189-5. PubMed PMID: 30606137.


Araghi M, Soerjomataram I, Bardot A, Ferlay J, Cabasag CJ, Morrison DS, De P, Tervonen H, Walsh PM, Bucher O, Engholm G, Jackson C, McClure C, Woods RR, Saint-Jacques N, Morgan E, Ransom D, Thursfield V, Møller B, Leonfellner S, Guren MG, Bray F, Arnold M. Changes in colorectal cancer incidence in seven high-income countries: a population-based study. Lancet Gastroenterol Hepatol. 2019 May 16. pii: S2468-1253(19)30147-5. doi: 10.1016/S2468-1253(19)30147-5. [Epub ahead of print] PubMed PMID: 31105047.


Arnold M, Rutherford MJ, Bardot A, Ferlay J, Andersson TML, Myklebust TA, Tervonen H, Thursfield V, Ransom D, Shack L, Woods RR, Turner D, Leonfellner S, Ryan S, Saint-Jacques N, De P, McClure C, Ramanakumar AV, Stuart-Panko H, Engholm G, Walsh PM, Jackson C, Vernon S, Morgan E, Gavin A, Morrison DS, Huws DW, Porter G, Butler J, Bryant H, Currow DC, Hiom S, Parkin EM, Sasieni P, Lambert PC, Møller B, Soerjomataram I, Bray F. Progress in cancer survival, mortality, and incidence in seven high-income countries 1995–2014 (ICBP SURVMARK-2): a population-based study. Lancet Oncol. 2019 Sep 11. doi: 10.1016/S1470-2045(19)30456-5. [Epub ahead of print] PubMed PMID: 31521509.


Asthana R, Zhang L, Wan BA, Gallo-Hershberg D, Giotis A, Pasetka M, van Draanen J, Goodall S, Diaz PL, Drost L, Chow E, De Angelis C. Pain descriptors of taxane acute pain syndrome (TAPS) in breast cancer patients-a prospective clinical study. Support Care Cancer. 2019 May 17. doi: 10.1007/s00520-019-04845-7. [Epub ahead of print] PubMed PMID: 31098795.


Bai L, Shin S, Burnett RT, Kwong JC, Hystad P, van Donkelaar A, Goldberg MS, Lavigne E, Weichenthal S, Martin RV, Copes R, Kopp A, Chen H. Exposure to ambient air pollution and the incidence of lung cancer and breast cancer in the Ontario Population Health and Environment Cohort (ONPHEC). Int J Cancer. 2019 Jul 15. doi: 10.1002/ijc.32575. [Epub ahead of print] PubMed PMID: 31304979. [Uses CCO data].


Bak K, Moody L, Wheeler SM, Gilbert J. Patient and Staff Engagement in Health System Improvement: A Qualitative Evaluation of the Experience-Based Co-design Approach in Canada. Healthc Q. 2018 Jul;21(2):24-29. doi: 10.12927/hcq.2018.25626. PubMed PMID: 30474588.


Barbera L, Lee F, Sutradhar R. Use of patient-reported outcomes in regional cancer centres over time: a retrospective study. CMAJ Open. 2019 Feb 18;7 1):E101-E108. doi: 10.9778/cmajo.20180074. Print 2019 Jan-Mar. PubMed PMID: 30782773; PubMed Central PMCID: PMC6380903. [Uses CCO data].


Beca J, Majeed H, Chan KKW, Hotte SJ, Loblaw A, Hoch JS. Cost-effectiveness of docetaxel in high-volume hormone-sensitive metastatic prostate cancer. Can Urol Assoc J. 2019 Apr 26. doi: 10.5489/cuaj.5889. [Epub ahead of print] PubMed PMID: 31039109.


Blackmore KM, Weerasinghe A, Holloway CMB, Majpruz V, Mirea L, O'Malley FP, Paroschy Harris C, Hendry A, Hey A, Kornecki A, Lougheed G, Maier BA, Marchand P, McCready D, Rand C, Raphael S, Segal-Nadler R, Sehgal N, Muradali D, Chiarelli AM. Comparison of wait times across the breast cancer treatment pathway among screened women undergoing organized breast assessment versus usual care. Can J Public Health. 2019 Apr 29. doi: 10.17269/s41997-019-00210-7. [Epub ahead of print] PubMed PMID: 31037608.


Bouchard-Fortier A, Baxter NN, Sutradhar R, Fernandes K, Camacho X, Graham P, Quan ML. Contralateral prophylactic mastectomy in young women with breast cancer: a population-based analysis of predictive factors and clinical impact. Curr Oncol. 2018 Dec;25(6):e562-e568. doi: 10.3747/co.25.4169. Epub 2018 Dec 1. PubMed PMID: 30607124; PubMed Central PMCID: PMC6291287. [Uses CCO data].


Brennan K, Karim S, Doiron RC, Siemens DR, Booth CM. Venous Thromboembolism and Peri-Operative Chemotherapy for Muscle-Invasive Bladder Cancer: A Population-based Study. Bladder Cancer. 2018 Oct 29;4(4):419-428. doi: 10.3233/BLC-180184. PubMed PMID: 30417053; PubMed Central PMCID: PMC6218104. [Uses CCO data]


Brenner DR, Friedenreich CM, Ruan Y, Poirier AE, Walter SD, King WD, Franco EL, Demers PA, Villeneuve PJ, Grevers X, Nuttall R, Smith LM, Volesky KD, O'Sullivan DE, De P; ComPARe Study Team. The burden of cancer attributable to modifiable risk factors in Canada: Methods overview. Prev Med. 2019 May;122:3-8. doi: 10.1016/j.ypmed.2019.03.007. PubMed PMID: 31078170.


Bridge E, Gotlib Conn L, Dhanju S, Singh S, Moody L. The patient experience of ambulatory cancer treatment: A descriptive study. Current Oncol. 2019 Aug;24(4):e482-e493. doi: 10.3747/co.26.4191.


Bubela T, Genuis SK, Janjua NZ, Krajden M, Mittmann N, Podolak K, Svenson LW. Medical Information Commons to Support Learning Healthcare Systems: Examples From Canada. J Law Med Ethics. 2019 Mar;47(1):97-105. doi: 10.1177/1073110519840488. PubMed PMID: 30994059.


Bogach J, Pond G, Esckicioglu C, Seow H. Age-Related Survival Differences in Patients With Inflammatory Bowel Disease-Associated Colorectal Cancer: A Population-Based Cohort Study. Inflamm Bowel Dis. 2019 May 8. pii: izz088. doi: 10.1093/ibd/izz088. [Epub ahead of print] PubMed PMID: 31066449. [Uses CCO data].


Canadian Cancer Society, Public Health Agency of Canada and Statistics Canada (with data from the Ontario Cancer Registry). CCO Collaborators: De P (CCO Liaison), King MJ, Raifu A. Canadian Cancer Statistics 2019. Annual online publication. [Uses CCO data].


Chang VC, Cotterchio M, Khoo E. Iron intake, body iron status, and risk of breast cancer: a systematic review and meta-analysis. BMC Cancer. 2019 Jun 6;19(1):543. doi: 10.1186/s12885-019-5642-0. PubMed PMID: 31170936; PubMed Central PMCID: PMC6555759.


Chiarelli AM, Blackmore KM, Mirea L, Done SJ, Majpruz V, Weerasinghe A, Rabeneck L, Muradali D. Annual versus biennial screening: diagnostic accuracy among concurrent cohorts within the Ontario Breast Screening Program. J Natl Cancer Inst. 2019 Jun 24. pii: djz131. doi: 10.1093/jnci/djz131. [Epub ahead of print] PubMed PMID: 31233138.


Chiarelli AM, Blackmore KM, Muradali D, Done SJ, Majpruz V, Weerasinghe A, Mirea L, Eisen A, Rabeneck L, Warner E. Performance measures of magnetic resonance imaging plus mammography in the High Risk Ontario Breast Screening Program. J Natl Cancer Inst. 2019 Jun 24. pii: djz079. doi: 10.1093/jnci/djz079. [Epub ahead of print] PubMed PMID: 31233143.


Conlon MS, Caswell JM, Santi SA, Ballantyne B, Meigs ML, Knight A, Earle CC, Hartman M. Access to Palliative Care for Cancer Patients Living in a Northern and Rural Environment in Ontario, Canada: The Effects of Geographic Region and Rurality on End-of-Life Care in a Population-Based Decedent Cancer Cohort. Clin Med Insights Oncol. 2019 Feb 14;13:1179554919829500. doi: 10.1177/1179554919829500. eCollection 2019. PubMed PMID: 30799969; PubMed Central PMCID: PMC6378418. [Uses CCO data]


Conlon MSC, Caswell JM, Knight A, Ballantyne B, Santi SA, Meigs ML, Earle CC, Hartman M. Impact of comprehensive hospice palliative care on end-of-life care: a propensity-score-matched retrospective observational study. CMAJ Open. 2019 Apr 4;7(2):E197-E202. doi: 10.9778/cmajo.20180148. Print 2019 Apr-Jun. PubMed PMID: 30948648. [Uses CCO data].


De Rubeis V, Cotterchio M, Smith BT, Griffith LE, Borgida A, Gallinger S, Cleary S, Anderson LN. Trajectories of body mass index, from adolescence to older adulthood, and pancreatic cancer risk; a population-based case-control study in Ontario, Canada. Cancer Causes Control. 2019 Jun 22. doi: 10.1007/s10552-019-01197-9. [Epub ahead of print] PubMed PMID: 31230151.


Decker K, Baines N, Muzyka C, Lee M, Mayrand MH, Yang H, Fung S, Mercer D, McFaul S, Kupets R, Savoie R, Lotocki R, Bentley J. Measuring colposcopy quality in Canada: development of population-based indicators. Curr Oncol. 2019 Jun;26(3):e286-e291. doi: 10.3747/co.26.4709. Epub 2019 Jun 1. PubMed PMID: 31285670; PubMed Central PMCID: PMC6588076.


Djalalov S, Beca J, Ewara EM, Hoch JS. A Comparison of Different Analysis Methods for Reconstructed Survival Data to Inform CostEffectiveness Analysis. Pharmacoeconomics. 2019 Oct 1. doi: 10.1007/s40273-019-00830-4. [Epub ahead of print] PubMed PMID: 31571137.


Dube C, Tinmouth J. Number of samples in faecal immunochemical test screening: more might be less. Lancet Gastroenterol Hepatol. 2019 Jun 10. pii: S2468-1253 19)30191-8. doi: 10.1016/S2468-1253(19)30191-8. [Epub ahead of print] PubMed PMID: 31196733.


Eden M, Harrison S, Griffin M, Lambe M, Pettersson D, Gavin A, Brewster DH, Lin Y, Johannesen TB, Milne RL, Farrugia H, Nishri D, King MJ, Huws DW, Warlow J, Turner D, Earle CC, Peake M, Rashbass J. Impact of variation in cancer registration practice on observed international cancer survival differences between International Cancer Benchmarking Partnership (ICBP) jurisdictions. Cancer Epidemiol. 2019 Jan 9;58:184-192. doi: 10.1016/j.canep.2018.10.019. [Epub ahead of print] PubMed PMID: 30639877.


El-Masri Z, De P, Smith LM, Holmes E, Nuttall RK, Brenner DR, Friedenreich CM; ComPARe Study Team. Maximizing research impacts on cancer prevention: An integrated knowledge translation approach used by the Canadian Population Attributable Risk of Cancer (ComPARe) study. Prev Med. 2019 May;122:148-154. doi: 10.1016/j.ypmed.2019.03.036. PubMed PMID: 31078168.


Evans WK, Truscott R, Cameron E, Rana S, Isaranuwatchai W, Haque M, Rabeneck L. Implementing smoking cessation within cancer treatment centres and potential economic impacts. Transl Lung Cancer Res. 2019 May;8(Suppl 1):S11-S20. doi: 10.21037/tlcr.2019.05.09. PubMed PMID: 31211102; PubMed Central PMCID: PMC6546624.


Furman M, Harild L, Anderson M, Irish J, Nguyen K, Wright FC. The Development of Practice Guidelines for a Palliative Care Multidisciplinary Case Conference. J Pain Symptom Manage. 2018 Feb;55(2):395-401. doi: 10.1016/j.jpainsymman.2017.08.016. Epub 2017 Sep 1. Review. PubMed PMID: 28867461.


Giuliani M, Brual J, Eng L, Liu G, Papadakos T, Giannopoulos E, Papadakos J. Investigating the Smoking Cessation Informational Needs of Cancer Patients and Informal Caregivers. J Cancer Educ. 2019 May 22. doi: 10.1007/s13187-019-01547-w. [Epub ahead of print] PubMed PMID: 31119706.


Glicksman R, Ang M, Murray E, Simniceanu C, Lockhart E, Gilbert J, Gutierrez E, Warde P. Improving Quality of Radiotherapy Care across Ontario Using a Community of Practice Approach. Pract Radiat Oncol. 2018 Nov 14. pii: S1879-8500(18)30319-9. doi: 10.1016/j.prro.2018.10.017. [Epub ahead of print] PubMed PMID: 30447404.


Gogna P, Narain TA, O'Sullivan DE, Villeneuve PJ, Demers PA, Hystad P, Brenner DR, Friedenreich CM, King WD; ComPARe Study Team. Estimates of the current and future burden of lung cancer attributable to PM(2.5) in Canada. Prev Med. 2019 May;122:91-99. doi: 10.1016/j.ypmed.2019.03.010. PubMed PMID: 31078178.


Gogna P, Narain TA, O'Sullivan DE, Villeneuve PJ, Demers PA, Hystad P, Brenner DR, Friedenreich CM, King WD; ComPARe Study Team. Estimates of the current and future burden of lung cancer attributable to residential radon exposure in Canada. Prev Med. 2019 May;122:100-108. doi: 10.1016/j.ypmed.2019.04.005. PubMed PMID: 31078163.


Goldberg M, Sutradhar R, Paszat L, Whelan TJ, Gu S, Fong C, Rakovitch E. Patterns of adjuvant care and outcomes of elderly women with stage I breast cancer after breast-conserving surgery: a population-based analysis. Breast Cancer Res Treat. 2019 Aug;176(3):657-667. doi: 10.1007/s10549-019-05266-0. Epub 2019 May 10. PubMed PMID: 31076954. [Uses CCO data].


Groome PA, Webber C, Whitehead M, Moineddin R, Grunfeld E, Eisen A, Gilbert J, Holloway C, Irish JC, Langley H. Determining the Cancer Diagnostic Interval Using Administrative Health Care Data in a Breast Cancer Cohort. JCO Clin Cancer Inform. 2019 May;(3):1-10. doi: 10.1200/CCI.18.00131. PubMed PMID: 31112418.


Gupta V, Bubis L, Kidane B, Mahar AL, Ringash J, Sutradhar R, Darling GE, Coburn NG. Readmission rates following esophageal cancer resection are similar at regionalized and non-regionalized centers: A population-based cohort study. J Thorac Cardiovasc Surg. 2019 May 3. pii: S0022-5223(19)30960-2. doi: 10.1016/j.jtcvs.2019.04.061. [Epub ahead of print] PubMed PMID: 31176552. [Uses CCO data].


Harlos C, Metser U, Poon R, MacCrostie P, Mason W. 18 F-Fluorodeoxyglucose positron-emission tomography for the investigation of malignancy in patients with suspected paraneoplastic neurologic syndromes and negative or indeterminate conventional imaging: a retrospective analysis of the Ontario PET Access Program, with systematic review and meta-analysis. Curr Oncol. 2019 Aug;26(4):e458-e465. doi: 10.3747/co.26.4583. Epub 2019 Aug 1. PubMed PMID: 31548813; PubMed Central PMCID: PMC6726279. [used CCO data]


Harnett N, Bak K, Zychla L, Gutierrez E, Warde P. Defining advanced practice in radiation therapy: A feasibility assessment of a new healthcare provider role in Ontario, Canada. Radiography (Lond). 2019 Aug;25(3):241-249. doi: 10.1016/j.radi.2019.02.007. Epub 2019 Feb 28. PubMed PMID: 31301782.


Henry NL, Somerfield MR, Abramson VG, Ismaila N, Allison KH, Anders CK, Chingos DT, Eisen A, Ferrari BL, Openshaw TH, Spears PA, Vikas P, Stearns V. Role of Patient and Disease Factors in Adjuvant Systemic Therapy Decision Making for Early-Stage, Operable Breast Cancer: Update of the ASCO Endorsement of the Cancer Care Ontario Guideline. J Clin Oncol. 2019 Jun 17:JCO1900948. doi: 10.1200/JCO.19.00948. [Epub ahead of print] PubMed PMID: 31206315.


Jackson R, Wang L, Jembere N, Murphy J, Kupets R. Why Do Women Get Cervical Cancer in an Organized Screening Program in Canada? J Low Genit Tract Dis. 2018 Nov 27. doi: 10.1097/LGT.0000000000000450. [Epub ahead of print] PubMed PMID: 30489433.


Jenkins MA, Win AK, Dowty JG, MacInnis RJ, Makalic E, Schmidt DF, Dite GS, Kapuscinski M, Clendenning M, Rosty C, Winship IM, Emery JD, Saya S, Macrae FA, Ahnen DJ, Duggan D, Figueiredo JC, Lindor NM, Haile RW, Potter JD, Cotterchio M, Gallinger S, Newcomb PA, Buchanan DD, Casey G, Hopper JL. Ability of known susceptibility SNPs to predict colorectal cancer risk for persons with and without a family history. Fam Cancer. 2019 Jun 17. doi: 10.1007/s10689-019-00136-6. [Epub ahead of print] PubMed PMID: 31209717.


Jiang H, Walter SD, Brown P, Raina P, Chiarelli AM. Estimation of the benefit and harms of including clinical breast examination in an organized breast screening program. Breast. 2018 Nov 28;43:105-112. doi: 10.1016/j.breast.2018.11.012. [Epub ahead of print] PubMed PMID: 30544057.


John-Baptiste AA, Li L, Isaranuwatchai W, Osuch E, Anderson KK. Healthcare utilization costs of emerging adults with mood and anxiety disorders in an early intervention treatment program compared to a matched cohort. Early Interv Psychiatry. 2019 Jan 27. doi: 10.1111/eip.12790. [Epub ahead of print] PubMed PMID: 30688032.


Jull J, Hizaka A, Sheppard AJ, Kewayosh A, Doering P, MacLeod L, Joudain G, Plourde J, Dorschner D; Inuit Medical Interpreter Team, Rand M, Habash M, Graham ID. An integrated knowledge translation approach to develop a shared decision-making strategy for use by Inuit in cancer care: a qualitative study. Curr Oncol. 2019 Jun;26(3):192-204. doi: 10.3747/co.26.4729. Epub 2019 Jun 1. PubMed PMID: 31285666; PubMed Central PMCID: PMC6588049.


Karim S, Wei X, Leveridge MJ, Siemens DR, Robinson AG, Bedard PL, Booth CM. Delivery of chemotherapy for testicular cancer in routine practice: population-based study. Urol Oncol. 2018 Nov 23. pii: S1078-1439(18)30434-4. doi: 10.1016/j.urolonc.2018.10.025. [Epub ahead of print] PubMed PMID: 30478011. [Uses CCO data].


Karim S, Booth CM, Brennan K, Peng Y, Siemens DR, Krzyzanowska MK, Mackillop WJ. Estimating the optimal rate of adjuvant chemotherapy utilization for stage III colon cancer. Cancer Med. 2019 Aug 12. doi: 10.1002/cam4.2456. [Epub ahead of print] PubMed PMID: 31407518. [Uses CCO data].


Karim S, Mackillop WJ, Brennan K, Peng Y, Siemens DR, Krzyzanowska MK, Booth CM. Estimating the optimal perioperative chemotherapy utilization rate for muscle-invasive bladder cancer. Cancer Med. 2019 Aug 31. doi: 10.1002/cam4.2449. [Epub ahead of print] PubMed PMID: 31472011. [Uses CCO data].


Keech J, Beca J, Eisen A, Kennedy E, Kim J, Kouroukis CT, Darling G, Ferguson SE, Finelli A, Petrella TM, Perry JR, Chan K, Gavura S. Impact of a novel prioritization framework on clinician-led oncology drug submissions. Curr Oncol. 2019 Apr;26(2):e155-e161. doi: 10.3747/co.26.4501. Epub 2019 Apr 1. PubMed PMID: 31043821; PubMed Central PMCID: PMC6476458.


Kendzerska T, Nickerson JW, Hsu AT, Gershon AS, Talarico R, Mulpuru S, Pakhale S, Tanuseputro P. End-of-life care in individuals with respiratory diseases: a population study comparing the dying experience between those with chronic obstructive pulmonary disease and lung cancer. Int J Chron Obstruct Pulmon Dis. 2019 Jul 31;14:1691-1701. doi: 10.2147/COPD.S210916. eCollection 2019. PubMed PMID: 31534323; PubMed Central PMCID: PMC6681558. [Uses CCO data].


Kim CS, Hannouf MB, Sarma S, Rodrigues GB, Rogan PK, Mahmud SM, Winquist E, Brackstone M, Zaric GS. Survival outcome differences based on treatments used and knowledge of the primary tumour site for patients with cancer of unknown and known primary in Ontario. Curr Oncol. 2018 Oct;25(5):307-316. doi: 10.3747/co.25.4003. Epub 2018 Oct 31. PubMed PMID: 30464680; PubMed Central PMCID: PMC6209558. [Uses CCO data].


Korkidakis A, Lajkosz K, Green M, Strobino D, Velez MP. Patterns of Referral for Fertility Preservation Among Female Adolescents and Young Adults with Breast Cancer: A Population-Based Study. J Adolesc Young Adult Oncol. 2019 Jan 24. doi: 10.1089/jayao.2018.0102. [Epub ahead of print] PubMed PMID: 30676852. [Uses CCO data].


Labrèche F, Kim J, Song C, Pahwa M, Ge CB, Arrandale VH, McLeod CB, Peters CE, Lavoué J, Davies HW, Nicol AM, Demers PA. The current burden of cancer attributable to occupational exposures in Canada. Prev Med. 2019 May;122:128-139. doi: 10.1016/j.ypmed.2019.03.016. PubMed PMID: 31078166.


Latchana N, Davis L, Coburn NG, Mahar A, Liu Y, Hammad A, Kagedan D, Elmi M, Siddiqui M, Earle CC, Hallet J. Population-based study of the impact of surgical and adjuvant therapy at the same or a different institution on survival of patients with pancreatic adenocarcinoma. BJS Open. 2018 Dec 5;3 1):85-94. doi: 10.1002/bjs5.50115. eCollection 2019 Feb. PubMed PMID: 30734019; PubMed Central PMCID: PMC6354229. [Uses CCO data].


Lavallée LT, Breau RH, Fergusson D, Walsh C, van Walraven C. Can We Use Administrative Data to Accurately Identify Patients Who Receive a Prostate Biopsy? JCO Clin Cancer Inform. 2018 Dec;2:1-10. doi: 10.1200/CCI.17.00143. PubMed PMID: 30652596. [Uses CCO data].


Lofters AK, McBride ML, Li D, Whitehead M, Moineddin R, Jiang L, Grunfeld E, Groome PA; CanIMPACT Team. Disparities in breast cancer diagnosis for immigrant women in Ontario and BC: results from the CanIMPACT study. BMC Cancer. 2019 Jan 9;19(1):42. doi: 10.1186/s12885-018-5201-0. PubMed PMID: 30626375. [Uses CCO data].


Lofters AK, Kopp A, Vahabi M, Glazier RH. Understanding those overdue for cancer screening by five years or more: A retrospective cohort study in Ontario, Canada. Prev Med. 2019 Aug 21:105816. doi: 10.1016/j.ypmed.2019.105816. [Epub ahead of print] PubMed PMID: 31445111. [Uses CCO data].


Logar-Henderson C, MacLeod JS, Arrandale VH, Holness DL, McLeod CB, Peter A, Demers PA. Adult Asthma among Workers in Ontario: Results from the Occupational Disease Surveillance System. Ann Am Thorac Soc. 2019 Jan 25. doi: 10.1513/AnnalsATS.201810-701OC. [Epub ahead of print] PubMed PMID: 30682323. (also used CCO data (OCR))


MacNeil SD, Patel K, Liu K, Shariff S, Yoo J, Nichols A, Fung K, Garg AX. Survival of patients with subglottic squamous cell carcinoma. Curr Oncol. 2018 Dec;25(6):e569-e575. doi: 10.3747/co.25.3864. Epub 2018 Dec 1. PubMed PMID: 30607125; PubMed Central PMCID: PMC6291284. [Uses CCO data].


McBride ML, Groome PA, Decker K, Kendell C, Jiang L, Whitehead M, Li D, Grunfeld E; CanIMPACT Team. Adherence to quality breast cancer survivorship care in four Canadian provinces: a CanIMPACT retrospective cohort study. BMC Cancer. 2019 Jul 4;19(1):659. doi: 10.1186/s12885-019-5882-z. PubMed PMID: 31272420. [Uses CCO data].


McLeod SL, McCarron J, Ahmed T, Grewal K, Mittmann N, Scott S, Ovens H, Garay J, Bullard M, Rowe BH, Dreyer J, Borgundvaag B. Interrater Reliability, Accuracy, and Triage Time Pre- and Post-implementation of a Real-Time Electronic Triage Decision-Support Tool. Ann Emerg Med. 2019 Sep 26. pii: S0196-0644(19)30665-1. doi: 10.1016/j.annemergmed.2019.07.048. [Epub ahead of print] PubMed PMID: 31564379.


Mackillop WJ, Kong W. Comparison of Methods for Measuring Radiotherapy Utilisation. Clin Oncol (R Coll Radiol). 2019 Apr 12. pii: S0936-6555(19)30145-1. doi: 10.1016/j.clon.2019.03.046. [Epub ahead of print] PubMed PMID: 30987879.


Meggetto O, Peirson L, Yakubu M, Farid-Kapadia M, Costa-Fagbemi M, Baidoobonso S, Moffatt J, Chun L, Chiarelli AM, Muradali D. Breast cancer risk and breast screening for trans people: an integration of 3 systematic reviews. CMAJ Open. 2019 Oct 1;7(3):E598-E609. doi: 10.9778/cmajo.20180028. Print 2019 Jul-Sep. PubMed PMID: 31575606.


Merchant SJ, Brogly SB, Booth CM, Goldie C, Peng Y, Nanji S, Patel SV, Lajkosz K, Baxter NN. Management of Cancer-Associated Intestinal Obstruction in the Final Year of Life. J Palliat Care. 2019 Jul 16:825859719861935. doi: 10.1177/0825859719861935. [Epub ahead of print] PubMed PMID: 31307272. [Uses CCO data].


Metser U, Prica A, Hodgson DC, Mozuraitis M, Eberg M, Mak V, Green B, Singnurkar A, Dudebout J, MacCrostie P, Tau N, Mittmann N, Langer DL. Effect of PET/CT on the Management and Outcomes of Participants with Hodgkin and Aggressive Non-Hodgkin Lymphoma: A Multicenter Registry. Radiology. 2018 Dec 4:181519. doi: 10.1148/radiol.2018181519. [Epub ahead of print] PubMed PMID: 30511907.


Monakova J, Wong J, Blais I, Langan A, Ratansi N, Morgan D, Baxter NN. Establishing funding rates for colonoscopy and gastroscopy procedures in Ontario. Curr Oncol. 2019 Apr;26(2):98-101. doi: 10.3747/co.26.4405. Epub 2019 Apr 1. PubMed PMID: 31043810; PubMed Central PMCID: PMC6476446.


Moran O, Eisen A, Demsky R, Blackmore K, Knight JA, Panchal S, Ginsburg O, Zbuk K, Yaffe M, Metcalfe KA, Narod SA, Kotsopoulos J. Predictors of mammographic density among women with a strong family history of breast cancer. BMC Cancer. 2019 Jun 26;19(1):631. doi: 10.1186/s12885-019-5855-2. PubMed PMID: 31242899.


Nash DM, Garg AX, Brimble KS, Markle-Reid M. Primary care provider perceptions of enablers and barriers to following guideline-recommended laboratory tests to confirm chronic kidney disease: a qualitative descriptive study. BMC Fam Pract. 2018 Dec 10;19(1):192. doi: 10.1186/s12875-018-0879-2. PubMed PMID: 30526501; PubMed Central PMCID: PMC6287355.


Nash DM, Markle-Reid M, Brimble KS, McArthur E, Roshanov PS, Fink JC, Weir MA, Garg AX. Nonsteroidal anti-inflammatory drug use and risk of acute kidney injury and hyperkalemia in older adults: a population-based study. Nephrol Dial Transplant. 2019 Jul 1;34(7):1145-1154. doi: 10.1093/ndt/gfz062. PubMed PMID: 31264694.


Navaranjan G, Chambers D, Thompson PA, Do M, Berriault C, Villeneuve PJ, Demers PA. Uncertainties associated with assessing Ontario uranium miners' exposure to radon daughters. J Radiol Prot. 2018 Nov 19. doi: 10.1088/1361-6498/aaf1eb. [Epub ahead of print] PubMed PMID: 30524032.


O'Sullivan DE, Brenner DR, Demers PA, Villeneuve PJ, Friedenreich CM, King WD; ComPARe Study Group. Indoor tanning and skin cancer in Canada: A meta-analysis and attributable burden estimation. Cancer Epidemiol. 2019 Jan 9;59:1-7. doi: 10.1016/j.canep.2019.01.004. [Epub ahead of print] PubMed PMID: 30639817.


O'Sullivan DE, Brenner DR, Villeneuve PJ, Walter SD, Demers PA, Friedenreich CM, King WD; ComPARe Study Team. Estimates of the current and future burden of melanoma attributable to ultraviolet radiation in Canada. Prev Med. 2019 May;122:81-90. doi: 10.1016/j.ypmed.2019.03.012. PubMed PMID: 31078176.


O'Sullivan DE, Brenner DR, Villeneuve PJ, Walter SD, Demers PA, Friedenreich CM, King WD; ComPARe Study Team. Corrigendum to "Estimates of the current and future burden of melanoma attributable to ultraviolet radiation in Canada" [Prev. Med. 122 (2019) 81-90]. Prev Med. 2019 Jun 18:105728. doi: 10.1016/j.ypmed.2019.05.016. [Epub ahead of print] PubMed PMID: 31227246.


Pahwa M, Labrèche F, Kim J, Harris MA, Song C, Peters CE, Arrandale VH, Davies H, McLeod CB, Demers PA. The impact of night shift work on breast cancer: Results from the Burden of Occupational Cancer in Canada Study. Am J Ind Med. 2019 Jun 6. doi: 10.1002/ajim.22999. [Epub ahead of print] PubMed PMID: 31172551.


Pahwa M, Beane Freeman LE, Spinelli JJ, Blair A, McLaughlin JR, Zahm SH, Cantor KP, Weisenburger DD, Punam Pahwa PP, Dosman JA, Demers PA, Harris SA. Glyphosate use and associations with non-Hodgkin lymphoma major histological sub-types: findings from the North American Pooled Project. Scand J Work Environ Health. 2019 Jun 27. pii: 3830. doi: 10.5271/sjweh.3830. [Epub ahead of print] PubMed PMID: 31246262.


Peters CE, Kim J, Song C, Heer E, Arrandale VH, Pahwa M, Labrèche F, McLeod CB, Davies HW, Ge CB, Demers PA. Burden of non-melanoma skin cancer attributable to occupational sun exposure in Canada. Int Arch Occup Environ Health. 2019 Jul 3. doi: 10.1007/s00420-019-01454-z. [Epub ahead of print] PubMed PMID: 31270593.


Pang J, D'Antonio C, Heale E, Boll P, Blake P, Evans JM, Hladunewich M. Provincial Needs Assessment to Determine the Current State of Glomerulonephritis Care in Ontario. Can J Kidney Health Dis. 2019 Sep 20;6:2054358119877405. doi: 10.1177/2054358119877405. eCollection 2019. PubMed PMID: 31565235; PubMed Central PMCID: PMC6755634.


Papadakos J, Agarwal A, Charow R, Quartey NK, D'Souza A, Giuliani M, Millar BA, Massey C, Shultz D, Chung C. Informational needs of brain metastases patients and their caregivers. Neurooncol Pract. 2019 Jan;6(1):47-60. doi: 10.1093/nop/npy008. Epub 2018 Apr 20. PubMed PMID: 31386069.


Papadakos JK, Charow RC, Papadakos CJ, Moody LJ, Giuliani ME. Evaluating cancer patient-reported outcome measures: Readability and implications for clinical use. Cancer. 2019 Jan 8. doi: 10.1002/cncr.31928. [Epub ahead of print] PubMed PMID: 30620401.


Pardini B, Corrado A, Paolicchi E, Cugliari G, Berndt SI, Bezieau S, Bien SA, Brenner H, Caan BJ, Campbell PT, Casey G, Chan AT, Chang-Claude J, Cotterchio M, Gala M, Gallinger SJ, Haile RW, Harrison TA, Hayes RB, Hoffmeister M, Hopper JL, Hsu L, Huyghe J, Jenkins MA, Le Marchand L, Lin Y, Lindor NM, Nan H, Newcomb PA, Ogino S, Potter JD, Schoen RE, Slattery ML, White E, Vodickova L, Vymetalkova V, Vodicka P, Gemignani F, Peters U, Naccarati A, Landi S. DNA repair and cancer in colon and rectum: Novel players in genetic susceptibility. Int J Cancer. 2019 Jun 17. doi: 10.1002/ijc.32516. [Epub ahead of print] PubMed PMID: 31209889.


Pezo RC, Yan AT, Earle C, Chan KK. Underuse of ECG monitoring in oncology patients receiving QT-interval prolonging drugs. Heart. 2019 May 25. pii: heartjnl-2018-314674. doi: 10.1136/heartjnl-2018-314674. [Epub ahead of print] PubMed PMID: 31129611. [Uses CCO data].


Raffoul A, Hobin EP, Sacco JE, Lee KM, Haines J, Robson PJ, Dodd KW, Kirkpatrick SI. School-Age Children Can Recall Some Foods and Beverages Consumed the Prior Day Using the Automated Self-Administered 24-Hour Dietary Assessment Tool (ASA24) without Assistance. J Nutr. 2019 Apr 22. pii: nxz013. doi: 10.1093/jn/nxz013. [Epub ahead of print] PubMed PMID: 31006813.


Ramkissoon A, Navaranjan G, Berriault C, Villeneuve PJ, Demers PA, Do MT. Histopathologic Analysis of Lung Cancer Incidence Associated with Radon Exposure among Ontario Uranium Miners. Int J Environ Res Public Health. 2018 Oct 31;15(11). pii: E2413. doi: 10.3390/ijerph15112413. PubMed PMID: 30384407. [OCRC]


Ren J, Yang W, Su J, Ren X, Fazelzad R, Albert T, Habbous S, Goldstein DP, de Almeida JR, Hansen A, Jang R, Bratman SV, Hope A, Chen R, Wang J, Xu Y, Cheng D, Zhao Y, Xu W, Liu G. Human Papillomavirus and p16 Immunostaining, Prevalence and Prognosis of Squamous Carcinoma of Unknown Primary in the Head and Neck Region. Int J Cancer. 2019 Jan 30. doi: 10.1002/ijc.32164. [Epub ahead of print] Review. PubMed PMID: 30698281


Saluja R, Everest L, Cheng S, Cheung M, Chan KKW. Assessment of Whether the American Society of Clinical Oncology's Value Framework and the European Society for Medical Oncology's Magnitude of Clinical Benefit Scale Measure Absolute or Relative Clinical Survival Benefit: A Meta-analysis of Randomized Clinical Trials. JAMA Oncol. 2019 May 16. doi: 10.1001/jamaoncol.2019.0818. [Epub ahead of print] PubMed PMID: 31095255.


Seung SJ, Hurry M, Hassan S, Walton RN, Evans WK. Cost-of-illness study for non-small-cell lung cancer using real-world data. Curr Oncol. 2019 Apr;26(2):102-107. doi: 10.3747/co.26.4555. Epub 2019 Apr 1. PubMed PMID: 31043811; PubMed Central PMCID: PMC6476449.


Shakik S, Arrandale V, Holness DL, MacLeod JS, McLeod CB, Peter A, Demers PA. Dermatitis among workers in Ontario: results from the Occupational Disease Surveillance System. Occup Environ Med. 2019 Jul 18. pii: oemed-2018-105667. doi: 10.1136/oemed-2018-105667. [Epub ahead of print] PubMed PMID: 31320492.


Sritharan J, MacLeod JS, Dakouo M, Qadri M, McLeod CB, Peter A, Demers PA. Breast cancer risk by occupation and industry in women and men: Results from the Occupational Disease Surveillance System (ODSS). Am J Ind Med. 2019 Jan 15. doi: 10.1002/ajim.22942. [Epub ahead of print] PubMed PMID: 30648268. (also used CCO data (OCR))


Sritharan J, MacLeod JS, McLeod CB, Peter A, Demers PA. Prostate cancer risk by occupation in the Occupational Disease Surveillance System (ODSS) in Ontario, Canada. Health Promot Chronic Dis Prev Can. 2019 May;39(5):178-186. doi: 10.24095/hpcdp.39.5.02. English, French. PubMed PMID: 31091061.


Stevenson JKR, Qiao Y, Chan KKW, Beca J, Isaranuwatchai W, Guo H, Schwartz D, Arias J, Gavura S, Dai WF, Kouroukis CT, Cheung MC. Improved survival in overweight and obese patients with aggressive B-cell lymphoma treated with rituximab-containing chemotherapy for curative intent. Leuk Lymphoma. 2018 Dec 5:1-9. doi: 10.1080/10428194.2018.1538509. [Epub ahead of print] PubMed PMID: 30516081. [also used CCO data (OCR)]


Stock D, Knight JA, Raboud J, Cotterchio M, Strohmaier S, Willett W, Eliassen AH, Rosner B, Hankinson SE, Schernhammer E. Rotating night shift work and menopausal age. Hum Reprod. 2019 Mar 1;34(3):539-548. doi: 10.1093/humrep/dey390. PubMed PMID: 30753548.


Sun A, Durocher-Allen LD, Ellis PM, Ung YC, Goffin JR, Ramchandar K, Darling G. Initial management of small-cell lung cancer (limited- and extensive-stage) and the role of thoracic radiotherapy and first-line chemotherapy: a systematic review. Curr Oncol. 2019 Jun;26(3):e372-e384. doi: 10.3747/co.26.4481. Epub 2019 Jun 1. Review. PubMed PMID: 31285682; PubMed Central PMCID: PMC6588077. [Durocher-Allen LD is PEBC]


Sutradhar R, Rostami M, Barbera L. Patient-reported symptoms improve performance of risk prediction models for ED visits among patients with cancer: a population-wide study in Ontario using administrative data. J Pain Symptom Manage. 2019 Jul 16. pii: S0885-3924(19)30380-X. doi: 10.1016/j.jpainsymman.2019.07.007. [Epub ahead of print] PubMed PMID: 31319103. [Uses CCO data].


Swaminath A, Vella ET, Ramchandar K, Robinson A, Simone C, Sun A, Ung YC, Yasufuku K, Ellis PM. Surgery after chemoradiotherapy in patients with stage III (N2 or N3, excluding T4) non-small-cell lung cancer: a systematic review. Curr Oncol. 2019 Jun;26(3):e398-e404. doi: 10.3747/co.26.4549. Epub 2019 Jun 1. Review. PubMed PMID: 31285684; PubMed Central PMCID: PMC6588069. [Vella ET is PEBC]


Tavasoli SM, Kane E, Kupets R. Impact of Patient-Directed Cytology Results Correspondence Program on Follow-Up of High-Grade Pap Tests. J Obstet Gynaecol Can. 2019 Apr 30. pii: S1701-2163(19)30078-7. doi: 10.1016/j.jogc.2019.02.007. [Epub ahead of print] PubMed PMID: 31053566.


Tørring ML, Falborg AZ, Jensen H, Neal RD, Weller D, Reguilon I; ICBP Working Group, Menon U, Vedsted P. Advanced-stage cancer and time to diagnosis: An International Cancer Benchmarking Partnership (ICBP) cross-sectional study. Eur J Cancer Care (Engl). 2019 May 22:e13100. doi: 10.1111/ecc.13100. [Epub ahead of print] PubMed PMID: 31119836. [CCO authors: Barisic A (as part of ICBP working group); used CCO data (OCR).]


Vaisson G, Witteman HO, Chipenda-Dansokho S, Saragosa M, Bouck Z, Bravo CA, Desveaux L, Llovet D, Presseau J, Taljaard M, Umar S, Grimshaw JM, Tinmouth J, Ivers NM. Testing e-mail content to encourage physicians to access an audit and feedback tool: a factorial randomized experiment. Curr Oncol. 2019 Jun;26(3):205-216. doi: 10.3747/co.26.4829. Epub 2019 Jun 1. PubMed PMID: 31285667; PubMed Central PMCID: PMC6588071.


Vela N, Bubis LD, Davis LE, Mahar AL, Kennedy E, Coburn NG. Comparison of Patient-Reported Outcomes in Laparoscopic and Open Right Hemicolectomy: A Retrospective Cohort Study. Dis Colon Rectum. 2019 Sep 20. doi: 10.1097/DCR.0000000000001485. [Epub ahead of print] PubMed PMID: 31567922. [Uses CCO data].


Walsh N, Zhang H, Hyland PL, Yang Q, Mocci E, Zhang M, ... Cotterchio M, ... Stolzenberg-Solomon RZ. Agnostic Pathway/Gene Set Analysis of Genome-Wide Association Data Identifies Associations for Pancreatic Cancer. J Natl Cancer Inst. 2018 Dec 12. doi: 10.1093/jnci/djy155. [Epub ahead of print] PubMed PMID: 30541042.


Wang X, Dai JY, Albanes D, Arndt V, Berndt SI, Bézieau S, Brenner H, Buchanan DD, Butterbach K, Caan B, Casey G, Campbell PT, Chan AT, Chen Z, Chang-Claude J, Cotterchio M, Easton DF, Giles GG, Giovannucci E, Grady WM, Hoffmeister M, Hopper JL, Hsu L, Jenkins MA, Joshi AD, Lampe JW, Larsson SC, Lejbkowicz F, Li L, Lindblom A, Le Marchand L, Martin V, Milne RL, Moreno V, Newcomb PA, Offitt K, Ogino S, Pharoah PDP, Pinchev M, Potter JD, Rennert HS, Rennert G, Saliba W, Schafmayer C, Schoen RE, Schrotz-King P, Slattery ML, Song M, Stegmaier C, Weinstein SJ, Wolk A, Woods MO, Wu AH, Gruber SB, Peters U, White E. Mendelian randomization analysis of C-reactive protein on colorectal cancer risk. Int J Epidemiol. 2018 Nov 21. doi: 10.1093/ije/dyy244. [Epub ahead of print] PubMed PMID: 30476131.


Weller D, Menon U, Zalounina Falborg A, Jensen H, Barisic A, Knudsen AK, Bergin RJ, Brewster DH, Cairnduff V, Gavin AT, Grunfeld E, Harland E, Lambe M, Law RJ, Lin Y, Malmberg M, Turner D, Neal RD, White V, Harrison S, Reguilon I; ICBP Module 4 Working Group, Vedsted P. Diagnostic routes and time intervals for patients with colorectal cancer in 10 international jurisdictions; findings from a cross-sectional study from the International Cancer Benchmarking Partnership (ICBP). BMJ Open. 2018 Nov 27;8(11):e023870. doi: 10.1136/bmjopen-2018-023870. PubMed PMID: 30482749.


Wheeler S, MacKay J, Moody L, D'Souza J, Gilbert J. Engaging Patient and Family Advisors in Health-Care System Planning: Experiences and Recommendations. J Patient Exp. 2019 Apr 29. doi: 10.1177/2374373519840343. [Epub ahead of print]


Zanchetta C, Irish JC, Waddell JP. The Road to Improving Access to Surgical Specialist Consultations: Ontario's Experience with Wait 1 Wait Time Data. Healthc Q. 2018 Oct;21(3):42-50. doi: 10.12927/hcq.2018.25701. PubMed PMID